211
Views
0
CrossRef citations to date
0
Altmetric
Articles

Hyperoside suppresses osteoclasts differentiation and function through downregulating TRAF6/p38 MAPK signaling pathway

, , , , , & show all
Pages 1157-1168 | Received 07 Jul 2021, Accepted 16 Mar 2022, Published online: 18 Apr 2022
 

Abstract

Hyperoside (HP), as a natural product, can promote proliferation and differentiation of osteoblasts and presents a protective effect on ovariectomized (OVX) mice. However, the inhibitory effect of HP on osteoclasts (OCs) and the potential mechanism remain to be elucidated. In this study, it was found that HP could effectively inhibit the differentiation and bone resorption of OCs, and its intrinsic molecular mechanism was related to the inhibition of TRAF6/p38 MAPK signaling pathway. Therefore, HP could be a promising natural compound for lytic bone diseases.

Graphical Abstract

Disclosure statement

The authors have no conflicting interests.

Additional information

Funding

This research was financially supported by the National Key R&D Program of China (2018YFC1708100); Guizhou Science and Technology Program (Qian Ke He Ji Chu ZK [2021] 520); Guizhou University Introduced Talent Research Project (Gui Da Ren Ji He Zi [2019] 29).

Log in via your institution

Log in to Taylor & Francis Online

PDF download + Online access

  • 48 hours access to article PDF & online version
  • Article PDF can be downloaded
  • Article PDF can be printed
USD 61.00 Add to cart

Issue Purchase

  • 30 days online access to complete issue
  • Article PDFs can be downloaded
  • Article PDFs can be printed
USD 426.00 Add to cart

* Local tax will be added as applicable

Related Research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.